Anti Rituximab antibody titer and therapeutic response in Non-Hodgkin Lymphoma Patient Receiving R-Chop Treatment
Background: Rituximab as a combination of chemotherapy (R-CHOP) is more effective in the treatment of Lymphoma Non-Hodgkini (NHL). Production of humoral immune response frequently decreases the efficacy of antibody therapy due to premature clearance of antibodies, thus limiting the effectiveness of...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article PeerReviewed |
| Language: | English English English |
| Published: |
UNIPRINT
2019
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/96196/1/Anti%20rituximab%20antibody%20titer%20and%20therapeutic%20response%20in%20non-hodgkin%20lymphoma%20patient%20receiving%20R-chop%20treatment.pdf http://repository.unair.ac.id/96196/2/Anti%20rituximab%20antibody%20titer.pdf http://repository.unair.ac.id/96196/3/Anti%20Rituximab%20antibody%20titer%20and%20therapeutic%20response%20in%20Non-Hodgkin%20Lymphoma%20Patient%20Receiving%20R-Chop%20Treatment.pdf http://repository.unair.ac.id/96196/ https://ysmu.am/website/documentation/files/f3873f16.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | English English English |
Internet
http://repository.unair.ac.id/96196/1/Anti%20rituximab%20antibody%20titer%20and%20therapeutic%20response%20in%20non-hodgkin%20lymphoma%20patient%20receiving%20R-chop%20treatment.pdfhttp://repository.unair.ac.id/96196/2/Anti%20rituximab%20antibody%20titer.pdf
http://repository.unair.ac.id/96196/3/Anti%20Rituximab%20antibody%20titer%20and%20therapeutic%20response%20in%20Non-Hodgkin%20Lymphoma%20Patient%20Receiving%20R-Chop%20Treatment.pdf
http://repository.unair.ac.id/96196/
https://ysmu.am/website/documentation/files/f3873f16.pdf